newsfilter
← Latest News
Business Wire·

Paragon Advances Registration-Ready CNS Asset Addressing Important Unmet Need and Closes Sale to Teva Pharmaceutical

Agreement highlights Paragon's ability to build companies around important science, advance registration-ready assets, and deliver value through strategic transactions Paragon Biosciences today announced the closing